A selective T-type Ca2+ channel blocker R(-) efonidipine

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 377, Issue 4-6, 2008, Pages 411-421

  Shin, Min Chul ^a,b   Kim, Chang Ju ^a,b   Min, Byung Il ^a,b   Ogawa, Sachie ^a,c   Tanaka, Eiichiro ^c   Akaike, Norio ^a  

^a KUMAMOTO HEALTH SCIENCE UNIVERSITY   (Japan)

^b Kyung Hee University Hospital   (South Korea)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ca2+ channels; Hippocampal CA1 neuron; R( ) efonidipine; T type

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; EFONIDIPINE; FLUNARIZINE; MIBEFRADIL; NYSTATIN; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; CALCIUM CURRENT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; HIPPOCAMPUS; NERVE CELL; NONHUMAN; PATCH CLAMP; RAT;

ANIMALS; BARIUM; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, T-TYPE; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUNARIZINE; MIBEFRADIL; NITROPHENOLS; NYSTATIN; ORGANOPHOSPHORUS COMPOUNDS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PYRAMIDAL CELLS; RATS; RATS, WISTAR; SODIUM CHANNELS;

EID: 45849109532     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0239-6     Document Type: Conference Paper

References (49)

1. Akaike N (1996) Heterogeneous distribution of LVA and HVA calcium channels in mammalian brain tissue. In: Tsien RW, Clozel JP, Nargeot J (eds) Low-Voltage-Activated T-type Calcium Channels, Adis International, Chester, pp 53-62
2. Akaike N, Harata N (1994) Nystatin perforated patch recording and its applications to analyses of intracellular mechanisms. Jpn J Physiol 44:433-473
3. Akaike N, Takahashi K (1992) Tetrodotoxin-sensitive calcium-conducting channels in the rat hippocampal CA1 region. J Physiol 450:529-546
4. Akaike N, Kanaide H, Kuga T, Nakamura M, Sadoshima J, Tomoike H (1989a) Low-voltage-activated calcium current in rat aorta smooth muscle cells in primary culture. J Physiol 416:141-160
5. Akaike N, Kostyuk PG, Osipchuk YV (1989b) Dihydropyridine-sensitive low-threshold calcium channels in isolated rat hypothalamic neurones. J Physiol 412:181-195
6. Akaike N, Takahashi K, Morimoto M (1991) Heterogeneous distribution of tetrodotoxin-sensitive calcium-conducting channels in rat hippocampal CA1 neurons. Brain Res 556:135-138
7. Alps BJ, Calder C, Hass WK, Wilson AD (1988) Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine against ischaemic injury in the hippocampus of the Mongolian gerbil. Br J Pharmacol 93:877-883
8. Artru AA, Michenfelder JD (1980) Cerebral protective, metabolic, and vascular effects of phenytoin. Stroke 11:377-382
9. Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57:411-425
10. Choi DW (1988) Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci 11:465-469
11. Cribbs LL, Lee JH, Yang J, Satin J, Zhang Y, Daud A, Barclay J, Williamson MP, Fox M, Rees M, Perez-Reyes E (1998) Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res 83:103-109
12. Cullen JP, Aldrete JA, Jankovsky L, Romo-Salas F (1979) Protective action of phenytoin in cerebral ischemia. Anesth Analg 58:165-169
13. Ertel SI, Ertel EA, Clozel JP (1997) T-type Ca2+ channels and pharmacological blockade: potential pathophysiological relevance. Cardiovasc Drugs Ther 11:723-739
14. Furukawa T, Miura R, Honda M, Kamiya N, Mori Y, Takeshita S, Isshiki T, Nukada T (2004) Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels. Br J Pharmacol 143:1050-1057
15. Furukawa T, Nagaoka K, Watari Y, Taiga K, Watanabe Y, Honda M, Koganwzawa T, Sagawa S (2005) The characterization of three kind of dihydropyridine calcium channel antagonists on T-type calcium channel subtypes. Jpn J Electrocardiol 22:46
16. Gomora JC, Xu L, Enyeart JA, Enyeart JJ (2000) Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells. J Pharmacol Exp Ther 292:96-103
17. Greenberg DA, Carpenter CL, Messing RO (1987) Ethanol-induced component of 45Ca2+ uptake in PC12 cells is sensitive to Ca2+ channel modulating drugs. Brain Res 410:143-146
18. Hermsmeyer K, Mishra S, Miyagawa K, Minshall R (1997) Physiologic and pathophysiologic relevance of T-type calcium-ion channels: potential indications for T-type calcium antagonists. Clin Ther 19(Suppl A):18-26
19. Horn R, Marty A (1988) Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol 92:145-159
20. Ishibashi H, Akaike N (1995) Somatostatin modulates high-voltage- activated Ca channels in freshly dissociated rat hippocampal neurons. J Neurophysiol 74:1028-1036
21. Ishibashi H, Rhee JS, Akaike N (1995) Regional difference of high voltage-activated Ca2+ channels in rat CNS neurones. Neuroreport 6:1621-1624
22. Lee JH, Daud AN, Cribbs LL, Lacerda AE, Pereverzev A, Klockner U, Schneider T, Perez-Reyes E (1999) Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. J Neurosci 19:1912-1921
23. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ, Barker JL (1986) NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 321:519-522
24. Massieu L, Garcia O (1998) The role of excitotoxicity and metabolic failure in the pathogenesis of neurological disorders. Neurobiology (Bp) 6:99-108
25. Matsumura T, Furuichi H, Izumi J, Suda H, Ito S, Takei M, Nishi N, Mori T, Tanaka Y, Kurimoto T (1995) Effect of efonidipine hydrochloride, a calcium channel blocker, on the experimental cerebral ischemia/anoxia. Nippon Yakurigaku Zasshi 105:437-446
26. Masumiya H, Shijuku T, Tanaka H, Shigenobu K (1998) Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect. Eur J Pharmacol 349:351-357
27. McDonough SI, Bean BP (1998) Mibefradil inhibition of T-type calcium channels in cerebellar Purkinje neurons. Mol Pharmacol 54:1080-1087
28. Mintz IM, Adams ME, Bean BP (1992) P-type calcium channels in rat central and peripheral neurons. Neuron 9:85-95
29. Nikonenko I, Bancila M, Bloc A, Muller D, Bijlenga P (2005) Inhibition of T-type calcium channels protects neurons from delayed ischemia-induced damage. Mol Pharmacol 68:84-89
30. Ono K, Lee TS, Kaku T, Arita M (2000) Pharmacological properties of the human cardiac cloned T-type calcium channel. Jpn J Electrocardiol 20:109-112
31. Perchenet L, Benardeau A, Ertel EA (2000) Pharmacological properties of Ca(V)3.2, a low voltage-activated Ca2+ channel cloned from human heart. Naunyn Schmiedebergs Arch Pharmacol 361:590-599
32. Perez-Reyes E (1999) Three for T: molecular analysis of the low voltage-activated calcium channel family. Cell Mol Life Sci 15;56(7-8):660-669
33. Perez-Reyes E, Cribbs LL, Daud A, Lacerda AE, Barclay J, Williamson MP, Fox M, Rees M, Lee JH (1998) Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature 391:896-900
34. Randall A, Tsien RW (1995) Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons. J Neurosci 15:2995-3012
35. Sakoda R, Kamikawaji Y, Seto K (1992) Synthesis of 1,4-dihydropyridine-5- phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3, 2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3- pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure. Chem Pharm Bull (Tokyo) 40:2362-2369
36. Snutch TP, Leonard JP, Gilbert MM, Lester HA, Davidson N (1990) Rat brain expresses a heterogeneous family of calcium channels. Proc Natl Acad Sci USA 87:3391-3395
37. Takahashi K, Akaike N (1991) Calcium antagonist effects on low-threshold (T-type) calcium current in rat isolated hippocampal CA1 pyramidal neurons. J Pharmacol Exp Therap 256:169-175
38. Takahashi K, Wakamori M, Akaike N (1989) Hippocampal CA1 pyramidal cells of rats have four voltage-dependent calcium conductances. Neurosci Lett 104:229-234
39. Tanaka H, Shigenobu K (2005) Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug development. J Pharmacol Sci 99:214-220
40. Tanaka H, Komikado C, Shimada H, Takeda K, Namekata I, Kawanishi T, Shigenobu K (2004) The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium. J Pharmacol Sci 96:499-501
41. Terada K, Ohya Y, Kitamura K, Kuriyama H (1987) Actions of flunarizine, a Ca++ antagonist, on ionic currents in fragmented smooth muscle cells of the rabbit small intestine. J Pharmacol Exp Ther 240:978-983
42. Tytgat J, Nilius B, Vereecke J, Carmeliet E (1988a) The T-type Ca channel in guinea-pig ventricular myocytes is insensitive to isoproterenol. Pflugers Arch 411:704-706
43. Tytgat J, Vereecke J, Carmeliet E (1988b) Differential effects of verapamil and flunarizine on cardiac L-type and T-type Ca channels. Naunyn Schmiedebergs Arch Pharmacol 337:690-692
44. Uneyama C, Uneyama H, Takahashi M, Akaike N (1993) Cytoplasmic pH regulates ATP-induced Ca(2+)-dependent K(+)-current oscillation in rat megakaryocytes. Biochem J 295(Pt 1):317-320
45. Van der Vring JA, Cleophas TJ, Van der Wall EE, Niemeyer MG (1999) T-channel-selective calcium channel blockade: a promising therapeutic possibility, only preliminarily tested so far: a review of published data. T-Channel Calcium Channel Blocker Study Group. Am J Ther 6:229-233
46. Viana F, Van den BL, Missiaen L, Vandenberghe W, Droogmans G, Nilius B, Robberecht W (1997) Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones. Cell Calcium 22:299-311
47. Yaari Y, Hamon B, Lux HD (1987) Development of two types of calcium channels in cultured mammalian hippocampal neurons. Science 235:680-682
48. Yokoyama T, Fujikura N, Masuda Y, Shikada K, Tanaka S (1996) Effects of efonidipine hydrochloride, a calcium antagonist derived from dihydropyridine, on acute myocardial ischemia in anesthetized open-chest dogs. Nippon Yakurigaku Zasshi 108:307-321
49. Zapater P, Moreno J, Horga JF (1997) Neuroprotection by the novel calcium antagonist PCA50938, nimodipine and flunarizine, in gerbil global brain ischemia. Brain Res 772:57-62